Sousa-Victor, P., Garca-Prat, L
These results are in line with the negative findings in a Se-sufficient Italian cohort, in which newly diagnosed GHT patients were randomly assigned to treatment with ATD (methimazole in a titration regimen) alone or in combination with Se (166 g/day as selenomethionine) [16]
Its less invasive, more affordable, and effective for improving mobility and reducing inflammation
Direct exposure to sunlight or even harsh, direct laboratory lighting can compromise the vial's contents over time
It is not FDA-approved for any indication
Maecenas sapien lectus, vehicula vel euismod sed, vulputate Proin volutpat vitae libero at tincidunt